Last updated on June 2018

Study of Motilitone to Treat Functional Dyspepsia


Brief description of study

This study is to evaluate efficacy of the investigational drug Motilitone at 90 mg in patients with Functional Dyspepsia as measured by change in maximum tolerated volume and aggregate symptom score on the nutrient drink test.

Clinical Study Identifier: NCT02365701

Contact Investigators or Research Sites near you

Start Over

Madhusudan Grover, MBBS

Mayo Clinic
Rochester, MN United States

Recruitment Status: Closed


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.